NCT01723722View on ClinicalTrials.gov

Treatment of Neonatal Abstinence Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Neonatal Abstinence Syndrome
Interventions
DRUG

Methadone

Concentration is 1mg/mL administered every 12 hours given on sliding scale in response to last NAS score.

DRUG

Diluted Deodorized Tincture of Opium

Concentration is 1:24 dilution for a concentration of 0.4%

Trial Locations (1)

04401

Eastern Maine Medical Center, Bangor

All Listed Sponsors
lead

Eastern Maine Medical Center

OTHER

NCT01723722 - Treatment of Neonatal Abstinence Syndrome | Biotech Hunter | Biotech Hunter